MetLife (MET) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

MET Stock Forecast

MetLife stock forecast is as follows: an average price target of $90.50 (represents a 11.23% upside from MET’s last price of $81.36) and a rating consensus of 'Buy', based on 11 wall street analysts offering a 1-year stock forecast.

MET Price Target

The average price target for MetLife (MET) is $90.50 based on 1-year price targets from 11 Wall Street analysts in the past 3 months, with a price target range of $96.00 to $83.00. This represents a potential 11.23% upside from MET's last price of $81.36.

MET Analyst Ratings

Buy

According to 11 Wall Street analysts, MetLife's rating consensus is 'Buy'. The analyst rating breakdown for MET stock is 0 'Strong Buy' (0.00%), 11 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

MetLife Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Oct 02, 2024	John Barnidge	Piper Sandler	$92.00	$81.78	12.50%	13.08%
Sep 04, 2024	Alex Scott	Barclays	$91.00	$77.52	17.39%	11.85%
Aug 01, 2024	Joshua Shanker	Bank of America Securities	$96.00	$76.85	24.92%	17.99%
Jul 10, 2024	Bob Huang	Morgan Stanley	$83.00	$69.92	18.71%	2.02%
May 22, 2024	Kevin Heal	Argus Research	$80.00	$73.15	9.36%	-1.67%
May 06, 2024	John Barnidge	Piper Sandler	$82.00	$70.94	15.60%	0.79%
Mar 13, 2024	Catherine Seifert	CFRA	$77.00	$72.67	5.96%	-5.36%
Jan 08, 2024	Alex Scott	Goldman Sachs	$80.00	$68.92	16.08%	-1.67%
Sep 14, 2023	Brett Linzey	Mizuho Securities	$145.00	$63.79	127.31%	78.22%
Feb 02, 2023		Morgan Stanley	$90.00	$72.68	23.83%	10.62%
Jan 10, 2023		Morgan Stanley	$88.00	$71.35	23.34%	8.16%
Jan 09, 2023		Goldman Sachs	$78.00	$73.58	6.01%	-4.13%
Jan 06, 2023		J.P. Morgan	$80.00	$73.58	8.73%	-1.67%
Dec 09, 2022		Jefferies	$82.00	$73.61	11.40%	0.79%
Nov 17, 2022		Morgan Stanley	$87.00	$74.01	17.55%	6.93%
Aug 22, 2022		Credit Suisse	$77.00	$67.39	14.26%	-5.36%
Aug 17, 2022		Morgan Stanley	$83.00	$67.25	23.42%	2.02%
Aug 04, 2022		Morgan Stanley	$79.00	$64.14	23.17%	-2.90%
Jul 14, 2022		Barclays	$75.00	$57.79	29.78%	-7.82%
Jul 06, 2022		Evercore ISI	$80.00	$61.40	30.29%	-1.67%
Jul 06, 2022		Morgan Stanley	$78.00	$61.59	26.65%	-4.13%
Jun 22, 2022	Charles Lederer	Wolfe Research	$74.00	$61.75	19.84%	-9.05%
May 05, 2022		Morgan Stanley	$80.00	$67.23	18.99%	-1.67%
Jan 05, 2022	Thomas Gallagher	Evercore ISI	$75.00	$64.18	16.86%	-7.82%
Dec 02, 2021	Alex Scott	Goldman Sachs	$77.00	$58.92	30.69%	-5.36%
May 13, 2021	Andrew Kligerman	Credit Suisse	$68.00	$63.12	7.73%	-16.42%
May 07, 2021	Kevin Heal	Argus Research	$72.00	$65.20	10.43%	-11.50%

The latest MetLife stock forecast, released on Oct 02, 2024 by John Barnidge from Piper Sandler, set a price target of $92.00, which represents a 12.50% increase from the stock price at the time of the forecast ($81.78), and a 13.08% increase from MET last price ($81.36).

MetLife Price Target by Period

	1M	3M	12M
# Anlaysts	-	1	8
Avg Price Target	-	$92.00	$85.13
Last Closing Price	$81.36	$81.36	$81.36
Upside/Downside	-100.00%	13.08%	4.63%

In the current month, the average price target of MetLife stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to MetLife's last price of $81.36. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 08, 2024	Cowen & Co.		Buy	Initialise
Oct 02, 2024	Piper Sandler	Overweight	Overweight	Hold
Sep 27, 2024	Jefferies	Buy	Buy	Hold
Sep 26, 2024	Evercore ISI	Outperform	Outperform	Hold
Aug 12, 2024	Wells Fargo	Overweight	Overweight	Hold
Jul 23, 2024	Citigroup	Buy	Buy	Hold
Jul 18, 2024	Jefferies	Buy	Buy	Hold
Jul 10, 2024	Morgan Stanley	Overweight	Overweight	Hold
May 06, 2024	Piper Sandler	Overweight	Overweight	Hold
Apr 11, 2024	Citigroup	Underperform	Underperform	Hold
Apr 05, 2024	Piper Sandler	Overweight	Overweight	Hold
Jan 08, 2024	Goldman Sachs	Neutral	Buy	Upgrade
Sep 14, 2023	Jefferies		Buy	Upgrade
Feb 02, 2023	Morgan Stanley	Overweight	Overweight	Hold
Jan 10, 2023	Morgan Stanley	Overweight	Overweight	Hold
Jan 09, 2023	Goldman Sachs		Neutral	Downgrade
Nov 17, 2022	Morgan Stanley	Overweight	Overweight	Hold
Aug 22, 2022	Credit Suisse	Outperform	Outperform	Hold
Aug 04, 2022	Morgan Stanley	Overweight	Overweight	Hold
Jul 14, 2022	Barclays	Overweight	Overweight	Hold
Jul 06, 2022	Evercore ISI	Outperform	Outperform	Hold
Jul 06, 2022	Morgan Stanley	Overweight	Overweight	Hold
Jun 22, 2022	Wolfe Research		Outperform	Upgrade
Feb 22, 2022	Morgan Stanley	Overweight	Overweight	Hold

MetLife's last stock rating was published by Cowen & Co. on Oct 08, 2024. The company Initialise its MET rating from "null" to "Buy".

MetLife Financial Forecast

MetLife Revenue Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$15.87B	$16.62B	$15.39B	$16.32B	$22.27B	$15.56B	$1.16B	$19.17B	$15.23B	$15.86B	$14.28B	$19.71B	$15.44B
Avg Forecast	$22.70B	$22.00B	$21.49B	$19.84B	$20.99B	$20.07B	$19.90B	$19.22B	$20.12B	$19.17B	$19.04B	$18.35B	$19.29B	$18.66B	$18.57B	$17.73B	$18.46B	$17.68B	$16.91B	$16.84B	$17.22B	$20.58B	$16.04B	$16.78B	$17.67B	$16.28B	$15.84B	$16.03B	$16.21B	$16.00B
High Forecast	$23.85B	$23.12B	$22.58B	$20.84B	$22.05B	$21.09B	$20.91B	$20.19B	$21.14B	$20.13B	$20.00B	$18.90B	$21.31B	$18.70B	$18.57B	$17.73B	$19.42B	$18.62B	$17.77B	$17.69B	$18.09B	$20.58B	$16.04B	$16.78B	$17.67B	$16.28B	$15.84B	$16.03B	$16.21B	$16.00B
Low Forecast	$21.83B	$21.16B	$20.67B	$19.08B	$20.18B	$19.30B	$19.14B	$18.48B	$19.35B	$18.43B	$18.31B	$17.60B	$18.32B	$18.62B	$18.57B	$17.73B	$17.72B	$16.71B	$16.26B	$16.19B	$16.55B	$20.58B	$16.04B	$16.78B	$17.67B	$16.28B	$15.84B	$16.03B	$16.21B	$16.00B
# Analysts	1	1	1	1	1	1	1	1	1	1	1	3	5	4	4	4	5	6	3	3	4	4	4	4	3	3	3	3	3	3
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.90%	0.98%	0.91%	0.95%	1.08%	0.97%	0.07%	1.08%	0.94%	1.00%	0.89%	1.22%	0.96%

MetLife's average Quarter revenue forecast for Dec 23 based on 5 analysts is $18.46B, with a low forecast of $17.72B, and a high forecast of $19.42B. MET's average Quarter revenue forecast represents a 16.33% increase compared to the company's last Quarter revenue of $15.87B (Sep 23).

MetLife EBITDA Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	1	1	1	1	1	1	1	1	1	1	1	3	5	4	4	4	5	6	3	3	4	4	4	4	3	3	3	3	3	3
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-78.00M	$-197.00M	$507.00M	$1.97B	$589.00M	$218.00M	$935.00M	$1.52B	$2.28B	$4.71B	$514.00M	$394.00M	$1.15B
Avg Forecast	$2.55B	$2.47B	$2.41B	$2.22B	$2.35B	$2.25B	$2.23B	$2.16B	$2.26B	$2.15B	$2.14B	$2.06B	$2.16B	$2.09B	$2.08B	$1.11B	$2.07B	$1.98B	$1.90B	$874.54M	$965.93M	$1.40B	$1.09B	$691.33M	$1.20B	$1.11B	$1.08B	$317.81M	$1.10B	$1.09B
High Forecast	$2.67B	$2.59B	$2.53B	$2.34B	$2.47B	$2.37B	$2.35B	$2.26B	$2.37B	$2.26B	$2.24B	$2.12B	$2.39B	$2.10B	$2.08B	$1.33B	$2.18B	$2.09B	$1.99B	$1.05B	$1.16B	$1.40B	$1.09B	$829.60M	$1.20B	$1.11B	$1.08B	$381.37M	$1.10B	$1.09B
Low Forecast	$2.45B	$2.37B	$2.32B	$2.14B	$2.26B	$2.17B	$2.15B	$2.07B	$2.17B	$2.07B	$2.05B	$1.97B	$2.05B	$2.09B	$2.08B	$885.03M	$1.99B	$1.87B	$1.82B	$699.63M	$772.74M	$1.40B	$1.09B	$553.07M	$1.20B	$1.11B	$1.08B	$254.25M	$1.10B	$1.09B
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.04%	-0.10%	0.58%	2.04%	0.42%	0.20%	1.35%	1.27%	2.05%	4.37%	1.62%	0.36%	1.05%

3 analysts predict MET's average Quarter EBITDA for Jun 23 to be $1.90B, with a high of $1.99B and a low of $1.82B. This is 274.16% upper than MetLife's previous annual EBITDA (Mar 23) of $507.00M.

MetLife Net Income Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	1	1	1	1	1	1	1	1	1	1	1	3	5	4	4	4	5	6	3	3	4	4	4	4	3	3	3	3	3	3
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$489.00M	$402.00M	$80.00M	$1.34B	$395.00M	$132.00M	$669.00M	$1.21B	$1.58B	$3.41B	$358.00M	$158.00M	$706.00M
Avg Forecast	$2.19B	$2.16B	$2.10B	$1.83B	$1.98B	$1.94B	$1.90B	$1.68B	$1.81B	$1.77B	$1.73B	$1.51B	$1.56B	$1.53B	$1.48B	$791.56M	$1.32B	$1.37B	$1.34B	$625.74M	$763.74M	$843.50M	$1.04B	$494.65M	$1.05B	$1.24B	$1.20B	$221.35M	$1.09B	$1.15B
High Forecast	$2.33B	$2.30B	$2.24B	$1.95B	$2.11B	$2.07B	$2.03B	$1.79B	$1.92B	$1.88B	$1.85B	$1.57B	$1.68B	$1.56B	$1.48B	$949.87M	$1.42B	$1.52B	$1.43B	$750.89M	$916.49M	$876.18M	$1.04B	$593.59M	$1.05B	$1.24B	$1.20B	$265.62M	$1.09B	$1.15B
Low Forecast	$2.08B	$2.05B	$2.00B	$1.74B	$1.88B	$1.85B	$1.81B	$1.60B	$1.71B	$1.68B	$1.65B	$1.46B	$1.44B	$1.49B	$1.48B	$633.25M	$1.18B	$1.24B	$1.27B	$500.59M	$610.99M	$810.83M	$1.04B	$395.72M	$1.05B	$1.24B	$1.20B	$177.08M	$1.09B	$1.15B
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.36%	0.30%	0.13%	1.76%	0.47%	0.13%	1.35%	1.15%	1.28%	2.83%	1.62%	0.15%	0.61%

MetLife's average Quarter net income forecast for Dec 23 is $1.32B, with a range of $1.18B to $1.42B. MET's average Quarter net income forecast represents a 170.66% increase compared to the company's last Quarter net income of $489.00M (Sep 23).

MetLife SG&A Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	1	1	1	1	1	1	1	1	1	1	1	3	5	4	4	4	5	6	3	3	4	4	4	4	3	3	3	3	3	3
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.48B	$1.57B	$1.45B	-	$1.43B	$1.65B	$1.40B	$1.30B	$1.42B	$1.56B	$1.38B
Avg Forecast	$1.99B	$1.93B	$1.88B	$1.74B	$1.84B	$1.76B	$1.74B	$1.68B	$1.76B	$1.68B	$1.67B	$1.61B	$1.69B	$1.63B	$1.63B	$1.70B	$1.62B	$1.55B	$1.48B	$1.34B	$1.04B	$1.80B	$1.40B	$1.06B	$1.55B	$1.43B	$1.39B	$877.37M	$1.42B	$1.40B
High Forecast	$2.09B	$2.02B	$1.98B	$1.82B	$1.93B	$1.85B	$1.83B	$1.77B	$1.85B	$1.76B	$1.75B	$1.65B	$1.87B	$1.64B	$1.63B	$2.03B	$1.70B	$1.63B	$1.56B	$1.61B	$1.25B	$1.80B	$1.40B	$1.27B	$1.55B	$1.43B	$1.39B	$1.05B	$1.42B	$1.40B
Low Forecast	$1.91B	$1.85B	$1.81B	$1.67B	$1.77B	$1.69B	$1.68B	$1.62B	$1.69B	$1.61B	$1.60B	$1.54B	$1.60B	$1.63B	$1.63B	$1.36B	$1.55B	$1.46B	$1.42B	$1.07B	$834.09M	$1.80B	$1.40B	$847.64M	$1.55B	$1.43B	$1.39B	$701.89M	$1.42B	$1.40B
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.10%	1.50%	0.81%	-	1.35%	1.06%	0.98%	0.94%	1.62%	1.10%	0.99%

MetLife's average Quarter SG&A projection for Jun 23 is $1.48B, based on 3 Wall Street analysts, with a range of $1.42B to $1.56B. The forecast indicates a 0.12% rise compared to MET last annual SG&A of $1.48B (Mar 23).

MetLife EPS Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	1	1	1	1	1	1	1	1	1	1	1	3	5	4	4	4	5	6	3	3	4	4	4	4	3	3	3	3	3	3
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$0.56	$0.48	$0.02	$1.69	$0.42	$0.13	$0.74	$1.44	$1.78	$3.85	$0.33	$0.14	$0.70
Avg Forecast	$3.11	$3.07	$2.99	$2.60	$2.82	$2.76	$2.70	$2.39	$2.57	$2.51	$2.46	$2.15	$2.21	$2.17	$2.10	$1.84	$1.88	$1.94	$1.90	$1.81	$1.67	$1.18	$1.45	$1.65	$1.47	$1.74	$1.68	$1.53	$1.52	$1.61
High Forecast	$3.31	$3.27	$3.18	$2.77	$3.00	$2.94	$2.88	$2.55	$2.73	$2.68	$2.62	$2.23	$2.39	$2.22	$2.10	$1.84	$2.02	$2.16	$2.03	$1.93	$1.78	$1.23	$1.45	$1.65	$1.47	$1.74	$1.68	$1.53	$1.52	$1.61
Low Forecast	$2.95	$2.91	$2.84	$2.47	$2.68	$2.63	$2.57	$2.27	$2.44	$2.38	$2.34	$2.08	$2.04	$2.12	$2.10	$1.84	$1.68	$1.77	$1.81	$1.72	$1.58	$1.13	$1.45	$1.65	$1.47	$1.74	$1.68	$1.53	$1.52	$1.61
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.29%	0.25%	0.01%	1.01%	0.36%	0.09%	0.45%	0.98%	1.02%	2.29%	0.22%	0.09%	0.43%

According to 5 Wall Street analysts, MetLife's projected average Quarter EPS for Dec 23 is $1.88, with a low estimate of $1.68 and a high estimate of $2.02. This represents a 235.86% increase compared to MET previous annual EPS of $0.56 (Sep 23).

MetLife Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
MET	MetLife	$81.25	$90.50	11.38%	Buy
JXN	Jackson Financial	$90.37	$92.67	2.55%	Hold
PRU	Prudential Financial	$118.89	$119.67	0.66%	Buy
AFL	Aflac	$102.75	$102.17	-0.56%	Hold
GL	Globe Life	$105.78	$103.71	-1.96%	Hold
UNM	Unum Group	$72.86	$67.40	-7.49%	Buy
LNC	Lincoln National	$32.46	$30.00	-7.58%	Hold
CNO	CNO Financial Group	$37.52	$33.00	-12.05%	Hold
MFC	Manulife Financial	$30.73	$25.86	-15.85%	Buy

MET Forecast FAQ

Is MetLife a good buy?

Yes, according to 11 Wall Street analysts, MetLife (MET) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 11 'Buy' recommendations, accounting for 100.00% of MET's total ratings.

What is MET's price target?

MetLife (MET) average price target is $90.5 with a range of $83 to $96, implying a 11.23% from its last price of $81.36. The data is based on 11 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will MetLife stock go up soon?

According to Wall Street analysts' prediction for MET stock, the company can go up by 11.23% (from the last price of $81.36 to the average price target of $90.5), up by 17.99% based on the highest stock price target, and up by 2.02% based on the lowest stock price target.

Can MetLife stock reach $120?

MET's average twelve months analyst stock price target of $90.5 does not support the claim that MetLife can reach $120 in the near future.

What are MetLife's analysts' financial forecasts?

MetLife's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $80.18B (high $84.23B, low $77.1B), average EBITDA is $8.99B (high $9.45B, low $8.65B), average net income is $7.51B (high $8.01B, low $7.14B), average SG&A $7.02B (high $7.37B, low $6.75B), and average EPS is $10.68 (high $11.38, low $10.14). MET's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $86.03B (high $90.38B, low $82.73B), average EBITDA is $9.65B (high $10.14B, low $9.28B), average net income is $8.27B (high $8.82B, low $7.86B), average SG&A $7.53B (high $7.91B, low $7.24B), and average EPS is $11.76 (high $12.53, low $11.17).

Did the MET's actual financial results beat the analysts' financial forecasts?

Based on MetLife's last annual report (Dec 2022), the company's revenue was $69.9B, which missed the average analysts forecast of $70.61B by -1.01%. Apple's EBITDA was $3.78B, missing the average prediction of $4.15B by -8.97%. The company's net income was $2.54B, missing the average estimation of $3.14B by -19.10%. Apple's SG&A was $5.89B, beating the average forecast of $5.31B by 10.98%. Lastly, the company's EPS was $2.93, missing the average prediction of $5.95 by -50.73%. In terms of the last quarterly report (Sep 2023), MetLife's revenue was $15.87B, missing the average analysts' forecast of $17.68B by -10.26%. The company's EBITDA was $-78M, missing the average prediction of $1.98B by -103.93%. MetLife's net income was $489M, missing the average estimation of $1.37B by -64.26%. The company's SG&A was $0, missing the average forecast of $1.55B by -100.00%. Lastly, the company's EPS was $0.56, missing the average prediction of $1.94 by -71.19%